<?xml version="1.0" encoding="UTF-8"?>
<p>As we have some proof of the contributing role of Th17 cells to the cytokine storm, Th17 cells may likely promote pulmonary edema, tissue damage, and lung failure. In line with this, targeting Th17 cells may be beneficial for some patients with COVID, especially in those with a dominant Th17 immune profile[
 <xref rid="B43" ref-type="bibr">43</xref>,
 <xref rid="B45" ref-type="bibr">45</xref>].
</p>
